Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2026-01-02 @ 1:00 AM
Study NCT ID:
NCT05498792
Status:
RECRUITING
Last Update Posted:
2025-04-04
First Post:
2022-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Sponsor:
Fox Chase Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MEL-212
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |